DeutschNewstral
Article
americanbazaaronline.com on 2018-09-18 17:00
Hingez Therapeutics, founded by Indian American Salim Shah, gets $1.8 million NIH grant to develop drug
Related news
- Bollywood actor Salim Shah headlines Sir Syed Day celebrationsamericanbazaaronline.com
- Indian American Salim Shah’s Sarfez Pharmaceuticals develops drug for heart and kidney failure patientsamericanbazaaronline.com
- Drug developed by Indian American Salim Shah’s company Sarfez receives FDA approvalamericanbazaaronline.com
Former NIH chief favored as Trump’s ‘therapeutics czar’POLITICO
Soluble Therapeutics receives $150K NIH grant to extend tech capabilitiesbizjournals.com
Ann Arbor-based Genomenon wins $1.8 million NIH grantcrainsdetroit.com
German-founded digital therapeutics startup Kaia Health raises $10 milliontech.eu- Longwood Fund-founded TScan Therapeutics files for $100M IPObizjournals.com
Retrophin, Founded by Martin Shkreli, Rebrands Itself as Travere Therapeuticswsj.com
Aurora Cannabis buys 1.8 per cent stake in CanniMed TherapeuticsThe Globe and Mail
NIH Zinc Fact Sheetinfowars.com
Salim arrested following car crashnews.com.au- HSPR Therapeutics wants to be known as the poster child for NIH grants. Literallyhome.crainscleveland.com
NIH gets a flat 2017 budget—if Congress can find another $1.8 billionArs Technica- Indian American Salim Shah’s Sarfez Pharmaceuticals to begin clinical trials for new heart failure drug early next yearamericanbazaaronline.com
Fauci successor named by NIHnwaonline.com- BAmerican Red Cross foundedbowienewsonline.com
- George Church-founded Dyno Therapeutics scores another major partner in Astellasbizjournals.com
- Pharma giant Eli Lilly acquires Washington University-founded startup Disarm Therapeutics for $135Mbizjournals.com
Ebola patient at NIH improvesWashington Post